# Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients

> **NCT07523334** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Elderly
- Noncardiac Surgery
- Delayed Neurocognitive Recovery
- Postoperative Delirium
- Esketamine

## Interventions

- **DRUG:** Esketamine 1
- **DRUG:** Esketamine 2
- **DRUG:** Esketamine 3
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT07523334
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07523334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07523334, "Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07523334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*